FOXO4-DRI Supplier China: Wholesale COA Guide

Define what the DRI designation means in the order

Write the full controlled product name, sequence or molecular reference, stereochemical configuration, termini or modifications where applicable, material form, purity target, strength, quantity and RUO status. Ask the supplier to confirm that the quoted material matches the exact DRI specification rather than a conventional-sequence FOXO4-related peptide. Require the same identifier on the COA, analytical sample, label and packing list. A generic FOXO4 name or product photograph is insufficient for technical release.

Compare 2mg and 10mg presentations carefully

Create separate quotation rows showing strength, vial count, units per kit, total nominal material, content tolerance, parent lot, finished lot and price basis. One 10mg vial is not operationally equivalent to five 2mg vials because filling, packaging and inventory controls differ. Ask whether both strengths share a parent lot and how genealogy and reconciliation are retained. Prohibit silent strength substitution and compare cost using total documented material and the same evidence scope.

Review identity evidence against the specification

Require HPLC and mass-spectrometry data connected to the exact lot and interpret them within method scope. Check expected molecular information based on the approved sequence, sample ID, full chromatogram, integration, test date, method reference, report number and authorization. Ask how the analytical strategy supports the specified DRI material and how sample handling is controlled. A high chromatographic purity value cannot by itself demonstrate every stereochemical attribute, vial quantity or other untested property.

Separate quantitative content from chromatographic purity

Ask which suitable quantitative method or controlled filling record supports the 2mg or 10mg claim and what tolerance applies. Confirm whether the amount means net FOXO4-DRI material or total lyophilized mass including other constituents. If a parent lot is divided between strengths, request reconciliation of issued, filled, rejected and remaining quantities. Keep molecular identity, specified configuration, purity and content as independent acceptance fields so one test result is not stretched beyond its purpose.

Qualify supplier accountability and repeat-lot control

Map the legal seller, synthesis site, laboratory, fill-and-finish site, release authority, inventory owner and dispatch entity. Ask who holds original records and investigates an atypical identity result, label error or quantity discrepancy. Confirm released stock, MOQ, lead time, document timing and change notification. For repeat procurement, reassess every new lot and require notice before a change in sequence specification, manufacturing or test site, method, filling, label or packaging.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• FOXO4-DRI 2mg
• FOXO4-DRI 10mg
• SS-31 Supplier Guide
• MOTS-c Supplier Guide

Frequently asked questions